MSF India Newsletter
March 2022

From a seven-year-old child to a mother of two children, drug-resistant tuberculosis is rampant among all age groups. Globally, TB is the leading killer among infectious diseases with one-third of these deaths occurred in India. Patients either do not receive timely, accurate diagnoses or are unable to access the new drug regimen of Bedaquiline and Delamanid. It is not just the medical treatment but psycho-social support, infection prevention control measures and public awareness to battle stigma, especially among peer groups, that play an equally important role in treating TB.
We are sharing with you stories of people from three generations living in Mumbai: a girl in paediatric care named Vaishnavi, a 26-years-old man Chetan who aspired to build a prosperous career abroad, and a 33-years-old TB survivor Namrata who is now a community health worker with MSF. All three of them are receiving or have already received medical treatment at the MSF TB clinic in Mumbai.

The humanitarian work should not stop. Help us save lives

World Hepatitis Day 2019 Meerut image
Ukraine Crisis

As people stuck in Mariupol, Ukraine, cling to life under a rain of bombs and brutal shelling, we hear from our staff member, Sasha, who recently managed to escape the city where "each day is like losing your whole life."

Mediterranean Migration
Unprecedented increase of scabies cases in Cox’s Bazar refugee camps
Climate change
MSF commits to reduce carbon emissions to help safeguard the most vulnerable
Measles poses deadly risk for malnourished children
Democratic Republic of Congo
Violence and sense of impunity force stop to lifesaving car

Doctors Without Borders India / Medecins Sans Frontieres
AISF Building, First floor
Amar Colony, Lajpat Nagar-IV
New Delhi-110024

Privacy Policy & Disclaimer